- Published on
Emergency And Acute Medicine - Anticholinergic Poisoning
Core Overview: Anticholinergic poisoning is caused by central and peripheral cholinergic blockade. Depending on the agent, antagonism may occur at muscarinic receptors (most common), nicotinic receptors, or both. Symptoms typically begin 15–30 minutes after ingestion, with effects lasting about 2–24 hours.
Common Causes: Many medications have anticholinergic properties that are usually mild at therapeutic doses but can become life-threatening in overdose. Frequent culprits include antihistamines, belladonna alkaloids and related compounds, antiparkinsonian agents, cyclic antidepressants, antipsychotics (neuroleptics), mydriatic eye drops, skeletal muscle relaxants (e.g., orphenadrine, cyclobenzaprine), antispasmodics, and certain mushrooms/plants (Amanita muscaria, Amanita pantherina, deadly nightshade, mandrake, henbane). Jimson weed may be smoked or ingested.
How It Presents: Clarify timing, dose, and exposure route. The classic toxidrome is often remembered as: “mad as a hatter” (delirium/AMS), “hot as a hare” (hyperthermia), “red as a beet” (flushed skin), “dry as a bone” (dry skin/mucosa), and “blind as a bat” (mydriasis with blurry vision). Findings may include hyperthermia and altered mental status; fixed mydriasis with loss of accommodation; sinus tachycardia, occasional dysrhythmias (typically only in massive ingestions), hypo/HTN, and rarely cardiogenic pulmonary edema; tachypnea or respiratory failure; decreased/absent bowel sounds, dysphagia, decreased GI motility, and reduced salivation; urinary retention; decreased sweating with dry, flushed skin; hallucinations, coma, or seizures.
Essential Evaluation: Diagnosis is clinical, based on toxidrome and a reliable exposure history when possible.
Recommended Tests: Obtain a urine toxicology screen if helpful for context; electrolytes, BUN/creatinine, glucose; CBC; CPK if rhabdomyolysis is a concern; urinalysis; and acetaminophen/salicylate levels to detect occult coingestions (e.g., combination nighttime products). ECG commonly shows sinus tachycardia; may reveal QRS prolongation, AV block, bundle branch block patterns, or dysrhythmias.
Key Differentials: Sympathomimetic intoxication, withdrawal syndromes, acute psychiatric conditions, sepsis, and thyroid disease.
Prehospital Actions: Bring all pills, bottles, and packaging to support accurate identification in the ED.
Immediate Stabilization: Prioritize ABCs—airway control can be critical. Provide supplemental oxygen, establish IV access, initiate cardiac monitoring and pulse oximetry, and consider naloxone, thiamine, and dextrose (D50 or bedside glucose-guided) when altered mental status is present.
Emergency Department Care: Management is largely supportive: IV rehydration with 0.9% NS and aggressive external cooling for hyperthermia. Use benzodiazepines to control agitation and seizures; avoid phenothiazines because they can worsen anticholinergic effects. Treat seizures with benzodiazepines and barbiturates if needed. Manage dysrhythmias with standard agents, but avoid class Ia antiarrhythmics due to quinidine-like effects seen with many anticholinergic drugs; sodium bicarbonate boluses may reverse these sodium-channel blockade effects. For decontamination, give activated charcoal for oral ingestions within about 1 hour when appropriate, and use ocular irrigation for eyedrop exposure.
Antidote Considerations: Physostigmine (Antilirium) is a reversible acetylcholinesterase inhibitor that crosses the blood–brain barrier and can temporarily reverse both central and peripheral effects. Consider it when peripheral anticholinergic signs are present plus severe features such as uncontrolled agitation or seizures not responding to conventional therapy. Use with caution if QRS is prolonged due to risks of dysrhythmias (including asystole), seizures, and cholinergic crises—continuous monitoring is required. Avoid physostigmine in cyclic antidepressant overdose and use caution/avoid in cardiovascular disease, asthma/bronchospasm, intestinal obstruction, heart block, peripheral vascular disease, or bladder obstruction.
Medication Options: Activated charcoal 1 g/kg PO; dextrose 50–100 mL D50 (peds: D25 2 mL/kg over 1 minute) IV and repeat if needed; diazepam 5–10 mg IV (peds 0.2–0.5 mg/kg) q10–15 min; lorazepam 2–4 mg IV (peds 0.03–0.05 mg/kg) q10–15 min; dopamine 2–20 μg/kg/min IV titrated for hypotension; phenobarbital 10–20 mg/kg IV loading dose (monitor respiration); thiamine 100 mg IV/IM (peds 50 mg). For physostigmine, 0.5–2.0 mg IV over 5 min (peds 0.02 mg/kg), repeat in 30–60 min if needed. First-line for agitation/seizures is lorazepam or diazepam; second-line is physostigmine with caution and toxicology input when available.
Disposition Guidance: ICU admission is appropriate for moderate-to-severe toxicity (temperature control, agitation control, seizure/dysrhythmia monitoring) and for any patient receiving physostigmine. Discharge may be reasonable for mild, improving symptoms after 6–8 hours of ED observation.
Referral And Follow-Up: Arrange substance use referral for recreational misuse, poison-prevention counseling for accidental exposures, and psychiatric evaluation for intentional ingestion. Ensure appropriate psychiatric follow-up for intentional overdoses.
Clinical Tips And Common Traps: Treat hyperthermia aggressively—antipyretics do not work for toxic hyperthermia. If physostigmine is considered, use it carefully with continuous monitoring and toxicology consultation when possible.
Core Overview: Anticholinergic poisoning is caused by central and peripheral cholinergic blockade. Depending on the agent, antagonism may occur at muscarinic receptors (most common), nicotinic receptors, or both. Symptoms typically begin 15–30 minutes after ingestion, with effects lasting about 2–24 hours.
Common Causes: Many medications have anticholinergic properties that are usually mild at therapeutic doses but can become life-threatening in overdose. Frequent culprits include antihistamines, belladonna alkaloids and related compounds, antiparkinsonian agents, cyclic antidepressants, antipsychotics (neuroleptics), mydriatic eye drops, skeletal muscle relaxants (e.g., orphenadrine, cyclobenzaprine), antispasmodics, and certain mushrooms/plants (Amanita muscaria, Amanita pantherina, deadly nightshade, mandrake, henbane). Jimson weed may be smoked or ingested.
How It Presents: Clarify timing, dose, and exposure route. The classic toxidrome is often remembered as: “mad as a hatter” (delirium/AMS), “hot as a hare” (hyperthermia), “red as a beet” (flushed skin), “dry as a bone” (dry skin/mucosa), and “blind as a bat” (mydriasis with blurry vision). Findings may include hyperthermia and altered mental status; fixed mydriasis with loss of accommodation; sinus tachycardia, occasional dysrhythmias (typically only in massive ingestions), hypo/HTN, and rarely cardiogenic pulmonary edema; tachypnea or respiratory failure; decreased/absent bowel sounds, dysphagia, decreased GI motility, and reduced salivation; urinary retention; decreased sweating with dry, flushed skin; hallucinations, coma, or seizures.
Essential Evaluation: Diagnosis is clinical, based on toxidrome and a reliable exposure history when possible.
Recommended Tests: Obtain a urine toxicology screen if helpful for context; electrolytes, BUN/creatinine, glucose; CBC; CPK if rhabdomyolysis is a concern; urinalysis; and acetaminophen/salicylate levels to detect occult coingestions (e.g., combination nighttime products). ECG commonly shows sinus tachycardia; may reveal QRS prolongation, AV block, bundle branch block patterns, or dysrhythmias.
Key Differentials: Sympathomimetic intoxication, withdrawal syndromes, acute psychiatric conditions, sepsis, and thyroid disease.
Prehospital Actions: Bring all pills, bottles, and packaging to support accurate identification in the ED.
Immediate Stabilization: Prioritize ABCs—airway control can be critical. Provide supplemental oxygen, establish IV access, initiate cardiac monitoring and pulse oximetry, and consider naloxone, thiamine, and dextrose (D50 or bedside glucose-guided) when altered mental status is present.
Emergency Department Care: Management is largely supportive: IV rehydration with 0.9% NS and aggressive external cooling for hyperthermia. Use benzodiazepines to control agitation and seizures; avoid phenothiazines because they can worsen anticholinergic effects. Treat seizures with benzodiazepines and barbiturates if needed. Manage dysrhythmias with standard agents, but avoid class Ia antiarrhythmics due to quinidine-like effects seen with many anticholinergic drugs; sodium bicarbonate boluses may reverse these sodium-channel blockade effects. For decontamination, give activated charcoal for oral ingestions within about 1 hour when appropriate, and use ocular irrigation for eyedrop exposure.
Antidote Considerations: Physostigmine (Antilirium) is a reversible acetylcholinesterase inhibitor that crosses the blood–brain barrier and can temporarily reverse both central and peripheral effects. Consider it when peripheral anticholinergic signs are present plus severe features such as uncontrolled agitation or seizures not responding to conventional therapy. Use with caution if QRS is prolonged due to risks of dysrhythmias (including asystole), seizures, and cholinergic crises—continuous monitoring is required. Avoid physostigmine in cyclic antidepressant overdose and use caution/avoid in cardiovascular disease, asthma/bronchospasm, intestinal obstruction, heart block, peripheral vascular disease, or bladder obstruction.
Medication Options: Activated charcoal 1 g/kg PO; dextrose 50–100 mL D50 (peds: D25 2 mL/kg over 1 minute) IV and repeat if needed; diazepam 5–10 mg IV (peds 0.2–0.5 mg/kg) q10–15 min; lorazepam 2–4 mg IV (peds 0.03–0.05 mg/kg) q10–15 min; dopamine 2–20 μg/kg/min IV titrated for hypotension; phenobarbital 10–20 mg/kg IV loading dose (monitor respiration); thiamine 100 mg IV/IM (peds 50 mg). For physostigmine, 0.5–2.0 mg IV over 5 min (peds 0.02 mg/kg), repeat in 30–60 min if needed. First-line for agitation/seizures is lorazepam or diazepam; second-line is physostigmine with caution and toxicology input when available.
Disposition Guidance: ICU admission is appropriate for moderate-to-severe toxicity (temperature control, agitation control, seizure/dysrhythmia monitoring) and for any patient receiving physostigmine. Discharge may be reasonable for mild, improving symptoms after 6–8 hours of ED observation.
Referral And Follow-Up: Arrange substance use referral for recreational misuse, poison-prevention counseling for accidental exposures, and psychiatric evaluation for intentional ingestion. Ensure appropriate psychiatric follow-up for intentional overdoses.
Clinical Tips And Common Traps: Treat hyperthermia aggressively—antipyretics do not work for toxic hyperthermia. If physostigmine is considered, use it carefully with continuous monitoring and toxicology consultation when possible.
- Published on
Emergency And Acute Medicine – Thoracic Aortic Dissection
Foundational Overview: Thoracic aortic dissection begins with an intimal tear, allowing blood to enter and propagate through the aortic media under systolic pressure. Systemic hypertension is the dominant precipitating factor. Dissection may extend distally to involve carotid, subclavian, or visceral branches, or proximally to affect the aortic root, coronary ostia, and pericardium. Proximal extension may result in coronary artery occlusion, acute aortic regurgitation, or cardiac tamponade.
Anatomic Classification:
Stanford system: Type A involves the ascending aorta; Type B originates distal to the ascending aorta.
DeBakey system: Type I begins at the aortic root or arch, Type II is confined to the ascending aorta, and Type III originates distal to the left subclavian artery.
Peak incidence occurs at 50–55 years for proximal dissections and 60–70 years for distal dissections. Pregnancy markedly increases risk; in women younger than 40 years, up to half of dissections occur during pregnancy.
Predisposing Causes:
Any condition that weakens aortic wall integrity may lead to dissection. Common factors include chronic hypertension, congenital heart disease (bicuspid aortic valve, coarctation), cystic medial degeneration, connective tissue disorders (Marfan syndrome, Ehlers–Danlos), pregnancy, vasculitides (e.g., lupus, syphilis, giant cell arteritis, Takayasu arteritis), prior cardiac surgery (CABG or valve repair), and tobacco use.
Clinical Presentation:
Pain is classically abrupt, severe, and sharp, though absent in up to 15% of patients. Ascending dissections often cause substernal pain, descending dissections interscapular pain, and abdominal involvement lumbar pain. Combined chest, back, and abdominal pain is common. Neurologic manifestations may include visual changes or focal deficits. Atypical symptoms—syncope, fever, nausea, vomiting, leg pain, or altered mental status—may delay diagnosis. Older adults are less likely to report sudden pain, pulse deficits, or aortic regurgitation and have higher mortality.
Examination Findings:
Hypertension is common, though 35–40% may be normotensive. Pulse or blood pressure differentials between limbs suggest branch vessel involvement. A murmur of acute aortic regurgitation (often musical or vibrating) is heard in up to one-third of patients. Shock may occur from tamponade or myocardial infarction due to coronary artery involvement. Presentations may mimic heart failure, limb ischemia, or stroke.
Immediate Assessment Priorities:
Electrocardiography helps evaluate ischemia or infarction; inferior MI may result from right coronary artery involvement. A normal ECG in the setting of sudden, severe chest or back pain should heighten suspicion for dissection rather than ischemia.
Diagnostic Evaluation:
Laboratory findings are nonspecific and may include leukocytosis, hematuria, elevated creatinine, increased amylase from bowel ischemia, or elevated cardiac enzymes. A D-dimer below 500 ng/mL reduces likelihood but is insufficient as a sole screening test.
Chest radiography may show mediastinal widening, abnormal aortic contour, or cardiomegaly from hemopericardium, though up to 18% of films are normal.
Echocardiography identifies complications; transesophageal echocardiography is useful in unstable patients.
CT angiography is the diagnostic modality of choice in most centers due to high sensitivity and rapid availability. MRI offers excellent accuracy but limited emergency access. Aortography and cardiac catheterization are now rarely first-line but may reveal an intimal flap during evaluation for ischemia.
Key Diagnostic Alternatives:
Acute coronary syndrome, unstable angina, pneumothorax, esophageal rupture, pulmonary embolism, pericarditis, pneumonia, and musculoskeletal pain.
Prehospital Care:
Provide oxygen, establish IV access, and initiate monitoring.
Early Stabilization:
Secure two large-bore IV lines, apply continuous cardiac monitoring and pulse oximetry, administer oxygen, and prepare blood for crossmatching.
Definitive Emergency Management:
Rapid blood pressure and heart rate control are essential to reduce aortic shear stress. Initiate IV β-blockade (esmolol or labetalol) before vasodilators. Nitroprusside may be added once adequate β-blockade is established.
Type A dissections require emergent cardiothoracic surgery. Stable Type B dissections are managed medically unless complications develop.
Pharmacologic Therapy:
Esmolol IV bolus followed by infusion or labetalol IV bolus and drip for rate and pressure control. Nitroprusside infusion may be titrated carefully in conjunction with β-blockade.
Disposition Planning:
All patients with acute thoracic aortic dissection require ICU admission and immediate cardiothoracic surgical consultation. There are no discharge candidates from the ED.
Follow-Up Strategy:
Long-term management requires close cardiology and cardiothoracic surgery follow-up.
Clinical Pearls And Pitfalls:
Ascending aortic dissection carries an untreated mortality approaching 75% within two weeks, with death rates of 1–3% per hour during the first 48 hours. Most patients experience sudden-onset, severe pain, but atypical presentations are common. Thrombolytics and anticoagulants may be fatal if dissection is misdiagnosed as myocardial infarction or pulmonary embolism. Maintain a high index of suspicion in patients with refractory chest pain or chest pain accompanied by neurologic, back, abdominal, or limb symptoms, particularly in the presence of hypertension, male sex, advanced age, pregnancy, cocaine use, connective tissue disease, bicuspid aortic valve, or prior cardiac surgery.
Foundational Overview: Thoracic aortic dissection begins with an intimal tear, allowing blood to enter and propagate through the aortic media under systolic pressure. Systemic hypertension is the dominant precipitating factor. Dissection may extend distally to involve carotid, subclavian, or visceral branches, or proximally to affect the aortic root, coronary ostia, and pericardium. Proximal extension may result in coronary artery occlusion, acute aortic regurgitation, or cardiac tamponade.
Anatomic Classification:
Stanford system: Type A involves the ascending aorta; Type B originates distal to the ascending aorta.
DeBakey system: Type I begins at the aortic root or arch, Type II is confined to the ascending aorta, and Type III originates distal to the left subclavian artery.
Peak incidence occurs at 50–55 years for proximal dissections and 60–70 years for distal dissections. Pregnancy markedly increases risk; in women younger than 40 years, up to half of dissections occur during pregnancy.
Predisposing Causes:
Any condition that weakens aortic wall integrity may lead to dissection. Common factors include chronic hypertension, congenital heart disease (bicuspid aortic valve, coarctation), cystic medial degeneration, connective tissue disorders (Marfan syndrome, Ehlers–Danlos), pregnancy, vasculitides (e.g., lupus, syphilis, giant cell arteritis, Takayasu arteritis), prior cardiac surgery (CABG or valve repair), and tobacco use.
Clinical Presentation:
Pain is classically abrupt, severe, and sharp, though absent in up to 15% of patients. Ascending dissections often cause substernal pain, descending dissections interscapular pain, and abdominal involvement lumbar pain. Combined chest, back, and abdominal pain is common. Neurologic manifestations may include visual changes or focal deficits. Atypical symptoms—syncope, fever, nausea, vomiting, leg pain, or altered mental status—may delay diagnosis. Older adults are less likely to report sudden pain, pulse deficits, or aortic regurgitation and have higher mortality.
Examination Findings:
Hypertension is common, though 35–40% may be normotensive. Pulse or blood pressure differentials between limbs suggest branch vessel involvement. A murmur of acute aortic regurgitation (often musical or vibrating) is heard in up to one-third of patients. Shock may occur from tamponade or myocardial infarction due to coronary artery involvement. Presentations may mimic heart failure, limb ischemia, or stroke.
Immediate Assessment Priorities:
Electrocardiography helps evaluate ischemia or infarction; inferior MI may result from right coronary artery involvement. A normal ECG in the setting of sudden, severe chest or back pain should heighten suspicion for dissection rather than ischemia.
Diagnostic Evaluation:
Laboratory findings are nonspecific and may include leukocytosis, hematuria, elevated creatinine, increased amylase from bowel ischemia, or elevated cardiac enzymes. A D-dimer below 500 ng/mL reduces likelihood but is insufficient as a sole screening test.
Chest radiography may show mediastinal widening, abnormal aortic contour, or cardiomegaly from hemopericardium, though up to 18% of films are normal.
Echocardiography identifies complications; transesophageal echocardiography is useful in unstable patients.
CT angiography is the diagnostic modality of choice in most centers due to high sensitivity and rapid availability. MRI offers excellent accuracy but limited emergency access. Aortography and cardiac catheterization are now rarely first-line but may reveal an intimal flap during evaluation for ischemia.
Key Diagnostic Alternatives:
Acute coronary syndrome, unstable angina, pneumothorax, esophageal rupture, pulmonary embolism, pericarditis, pneumonia, and musculoskeletal pain.
Prehospital Care:
Provide oxygen, establish IV access, and initiate monitoring.
Early Stabilization:
Secure two large-bore IV lines, apply continuous cardiac monitoring and pulse oximetry, administer oxygen, and prepare blood for crossmatching.
Definitive Emergency Management:
Rapid blood pressure and heart rate control are essential to reduce aortic shear stress. Initiate IV β-blockade (esmolol or labetalol) before vasodilators. Nitroprusside may be added once adequate β-blockade is established.
Type A dissections require emergent cardiothoracic surgery. Stable Type B dissections are managed medically unless complications develop.
Pharmacologic Therapy:
Esmolol IV bolus followed by infusion or labetalol IV bolus and drip for rate and pressure control. Nitroprusside infusion may be titrated carefully in conjunction with β-blockade.
Disposition Planning:
All patients with acute thoracic aortic dissection require ICU admission and immediate cardiothoracic surgical consultation. There are no discharge candidates from the ED.
Follow-Up Strategy:
Long-term management requires close cardiology and cardiothoracic surgery follow-up.
Clinical Pearls And Pitfalls:
Ascending aortic dissection carries an untreated mortality approaching 75% within two weeks, with death rates of 1–3% per hour during the first 48 hours. Most patients experience sudden-onset, severe pain, but atypical presentations are common. Thrombolytics and anticoagulants may be fatal if dissection is misdiagnosed as myocardial infarction or pulmonary embolism. Maintain a high index of suspicion in patients with refractory chest pain or chest pain accompanied by neurologic, back, abdominal, or limb symptoms, particularly in the presence of hypertension, male sex, advanced age, pregnancy, cocaine use, connective tissue disease, bicuspid aortic valve, or prior cardiac surgery.
- Published on
Emergency and Acute Medicine – Ankle Sprain
Core Description
Ankle sprains involve injury to the ligamentous stabilizers of the ankle joint, a hinge joint formed by the tibia, fibula, and talus. Injury severity ranges from ligament stretching with microscopic damage (grade I), to partial tearing (grade II), to complete ligament rupture (grade III).
Mechanisms And Causes
Ankle sprains most often result from forced inversion or eversion, frequently during sports or collisions. Approximately 85–90% involve the lateral ligament complex, including the anterior talofibular, posterior talofibular, and calcaneofibular ligaments. Inversion injury most commonly affects the anterior talofibular ligament; calcaneofibular ligament injury is more likely when the ankle is in neutral position, while isolated posterior talofibular ligament injury is rare. Deltoid ligament injuries typically result from eversion and are often associated with medial malleolar avulsion or talar insertion injury; isolated deltoid injuries are uncommon and should raise concern for associated lateral malleolus or proximal fibular (Maisonneuve) fracture. Syndesmotic sprains involve the distal tibiofibular ligaments, occur frequently in collision sports, and carry higher morbidity with risk of long-term complications. In children younger than 10 years, traumatic ankle pain with normal radiographs most commonly represents a Salter–Harris type I fracture, as the physis is weaker than surrounding ligaments.
Clinical Presentation
Patients usually present with ankle pain, swelling, and difficulty bearing weight. History should include time and mechanism of injury, presence of a pop or crack, prior ankle trauma, relevant medical conditions, treatments attempted before arrival, and ability to bear weight at the scene and in the emergency department. Physical examination focuses on detecting instability and associated injury, including bony tenderness along the posterior edges of the medial and lateral malleoli and the base of the fifth metatarsal, distal neurovascular status, and comparison of range of motion with the uninjured side. Stress testing is often limited by pain. The squeeze test helps identify syndesmotic injury when compression of the tibia and fibula at the midcalf reproduces ankle pain.
Imaging Decision Strategy
The Ottawa Ankle Rules provide a validated approach for determining the need for radiographs. Imaging is recommended for bony tenderness at the posterior edge or distal 6 cm of either malleolus, tenderness at the base of the fifth metatarsal or navicular, or inability to bear weight for four unassisted steps both immediately after injury and in the emergency department.
Diagnostic Evaluation
Radiographs should be obtained when fracture is suspected. Stress radiographs are rarely useful acutely and should not be routinely ordered unless requested by a consultant.
Differential Considerations
Ankle fracture or dislocation, Achilles tendon rupture, Maisonneuve fracture, os trigonum fracture, fifth metatarsal fracture, talar dome lesion, and peroneal tendon injury should be considered.
Initial Management
Prehospital care includes immobilization as needed to reduce pain and prevent further injury.
Emergency Department Care
Initial therapy focuses on preventing further injury and avoiding painful weight bearing using rest, ice, compression, and elevation. Treatment aims to reduce pain and restore function without chronic instability. Evidence supports early mobilization with functional treatment. Grade I and II sprains are managed with elastic bandaging combined with an air-stirrup or gel splint and weight bearing as tolerated. Grade III sprains or those with severe pain may benefit from brief immobilization followed by early functional rehabilitation and orthopedic referral. Crutches may be used initially for comfort. Once swelling and pain resolve, strengthening and proprioceptive exercises improve recovery and reduce reinjury. Return to sports should occur only when running and directional changes are pain free. Bracing or taping reduces recurrence in high-risk sports.
Pharmacologic Therapy
NSAIDs are effective for acute pain control, including oral ibuprofen or topical diclofenac gel. Opioid analgesics may be required for severe pain.
Disposition And Follow-Up
Isolated ankle sprains do not require admission and may be discharged with appropriate treatment, prescriptions, and aftercare instructions. Copies of radiographs may assist early follow-up. Grade I and II sprains should follow up with primary care within 1–2 weeks, while grade III sprains and syndesmotic injuries require orthopedic or sports medicine evaluation within 7–10 days.
Clinical Pearls And Common Errors
Appropriate application of the Ottawa Ankle Rules reduces unnecessary imaging. Functional treatment with early mobilization shortens recovery time, while prolonged immobilization increases the risk of chronic pain and recurrent instability.
Core Description
Ankle sprains involve injury to the ligamentous stabilizers of the ankle joint, a hinge joint formed by the tibia, fibula, and talus. Injury severity ranges from ligament stretching with microscopic damage (grade I), to partial tearing (grade II), to complete ligament rupture (grade III).
Mechanisms And Causes
Ankle sprains most often result from forced inversion or eversion, frequently during sports or collisions. Approximately 85–90% involve the lateral ligament complex, including the anterior talofibular, posterior talofibular, and calcaneofibular ligaments. Inversion injury most commonly affects the anterior talofibular ligament; calcaneofibular ligament injury is more likely when the ankle is in neutral position, while isolated posterior talofibular ligament injury is rare. Deltoid ligament injuries typically result from eversion and are often associated with medial malleolar avulsion or talar insertion injury; isolated deltoid injuries are uncommon and should raise concern for associated lateral malleolus or proximal fibular (Maisonneuve) fracture. Syndesmotic sprains involve the distal tibiofibular ligaments, occur frequently in collision sports, and carry higher morbidity with risk of long-term complications. In children younger than 10 years, traumatic ankle pain with normal radiographs most commonly represents a Salter–Harris type I fracture, as the physis is weaker than surrounding ligaments.
Clinical Presentation
Patients usually present with ankle pain, swelling, and difficulty bearing weight. History should include time and mechanism of injury, presence of a pop or crack, prior ankle trauma, relevant medical conditions, treatments attempted before arrival, and ability to bear weight at the scene and in the emergency department. Physical examination focuses on detecting instability and associated injury, including bony tenderness along the posterior edges of the medial and lateral malleoli and the base of the fifth metatarsal, distal neurovascular status, and comparison of range of motion with the uninjured side. Stress testing is often limited by pain. The squeeze test helps identify syndesmotic injury when compression of the tibia and fibula at the midcalf reproduces ankle pain.
Imaging Decision Strategy
The Ottawa Ankle Rules provide a validated approach for determining the need for radiographs. Imaging is recommended for bony tenderness at the posterior edge or distal 6 cm of either malleolus, tenderness at the base of the fifth metatarsal or navicular, or inability to bear weight for four unassisted steps both immediately after injury and in the emergency department.
Diagnostic Evaluation
Radiographs should be obtained when fracture is suspected. Stress radiographs are rarely useful acutely and should not be routinely ordered unless requested by a consultant.
Differential Considerations
Ankle fracture or dislocation, Achilles tendon rupture, Maisonneuve fracture, os trigonum fracture, fifth metatarsal fracture, talar dome lesion, and peroneal tendon injury should be considered.
Initial Management
Prehospital care includes immobilization as needed to reduce pain and prevent further injury.
Emergency Department Care
Initial therapy focuses on preventing further injury and avoiding painful weight bearing using rest, ice, compression, and elevation. Treatment aims to reduce pain and restore function without chronic instability. Evidence supports early mobilization with functional treatment. Grade I and II sprains are managed with elastic bandaging combined with an air-stirrup or gel splint and weight bearing as tolerated. Grade III sprains or those with severe pain may benefit from brief immobilization followed by early functional rehabilitation and orthopedic referral. Crutches may be used initially for comfort. Once swelling and pain resolve, strengthening and proprioceptive exercises improve recovery and reduce reinjury. Return to sports should occur only when running and directional changes are pain free. Bracing or taping reduces recurrence in high-risk sports.
Pharmacologic Therapy
NSAIDs are effective for acute pain control, including oral ibuprofen or topical diclofenac gel. Opioid analgesics may be required for severe pain.
Disposition And Follow-Up
Isolated ankle sprains do not require admission and may be discharged with appropriate treatment, prescriptions, and aftercare instructions. Copies of radiographs may assist early follow-up. Grade I and II sprains should follow up with primary care within 1–2 weeks, while grade III sprains and syndesmotic injuries require orthopedic or sports medicine evaluation within 7–10 days.
Clinical Pearls And Common Errors
Appropriate application of the Ottawa Ankle Rules reduces unnecessary imaging. Functional treatment with early mobilization shortens recovery time, while prolonged immobilization increases the risk of chronic pain and recurrent instability.
- Published on
Emergency and Acute Medicine – Juvenile Idiopathic Arthritis
Overview And Definition
Juvenile idiopathic arthritis (JIA), formerly termed juvenile rheumatoid arthritis, represents a group of chronic inflammatory arthritides beginning before 17 years of age and persisting for more than six weeks without an identifiable cause. It is the most common chronic rheumatologic disease of childhood, affecting up to 1 in 1,000 children, with a female predominance in most subtypes. JIA encompasses a heterogeneous spectrum of disease, and fewer than half of affected children achieve complete remission, with many experiencing relapsing or persistent disease into adulthood.
Pathophysiology And Disease Classification
JIA is believed to result from immune dysregulation triggered by environmental factors in genetically predisposed children. The condition is classified into several subtypes based on joint involvement, symmetry, systemic features, laboratory findings, and family history. These include systemic-onset, pauciarticular, polyarticular (RF-positive and RF-negative), psoriatic, enthesitis-related, and unclassified forms. Prognosis varies by subtype, with pauciarticular disease generally carrying the most favorable outcome.
Clinical Subtypes And Presentations
Systemic-onset JIA accounts for a minority of cases and affects boys and girls equally. It is characterized by high, quotidian fevers lasting longer than two weeks, often accompanied by arthritis that may appear weeks to months after fever onset. Additional features may include a transient salmon-colored rash, lymphadenopathy, hepatosplenomegaly, or serositis. These patients often appear acutely ill and are at significant risk for macrophage activation syndrome, a life-threatening hyperinflammatory condition with high mortality.
Pauciarticular JIA is the most common subtype and typically affects young girls between two and four years of age. It involves four or fewer joints within the first six months, most often the knees, and presents insidiously in otherwise well-appearing children. Uveitis occurs in a substantial proportion and may be asymptomatic, necessitating routine ophthalmologic screening. Some children progress to extended disease with a worse prognosis.
Polyarticular JIA involves five or more joints within six months and may resemble adult rheumatoid arthritis, particularly in older girls with positive rheumatoid factor. Joint involvement is often symmetric, affecting both small and large joints, and may include the cervical spine and temporomandibular joint. Systemic symptoms are generally mild, limited to fatigue or anemia.
Psoriatic JIA presents with asymmetric arthritis of large joints, frequently involving the lower extremities or spine, and may be associated with psoriasis, dactylitis, nail pitting, or a family history of psoriasis. Enthesitis-related arthritis primarily affects older boys and involves lower extremity joints and the sacroiliac region, often accompanied by limited spinal motion and uveitis.
History And Physical Examination
The hallmark presentation of JIA is gradual-onset joint stiffness and swelling that is worse in the morning or after periods of inactivity and improves with movement. Children with systemic-onset disease are more likely to present to the emergency department due to acute illness, whereas other subtypes evolve slowly. Rapid onset of severe pain, warmth, and erythema in a joint is atypical for JIA and should prompt evaluation for infection or other inflammatory causes. Physical examination should focus on identifying systemic illness, documenting joint involvement, assessing range of motion, and noting signs of inflammation or functional impairment.
Initial Evaluation And Diagnostic Strategy
The primary objectives in the acute setting are to exclude septic arthritis, malignancy, and other identifiable causes of joint inflammation, as well as complications related to long-term immunosuppressive therapy. Basic laboratory studies include complete blood count and inflammatory markers, with blood cultures added if the child appears ill. Additional testing such as ANA, RF, HLA-B27, and liver enzymes may aid in subtype classification. Imaging with plain radiographs may show early soft tissue swelling and effusion, with later findings including osteoporosis and joint destruction. Ultrasound is helpful for detecting small effusions and guiding arthrocentesis when infection is suspected.
Differential Diagnostic Considerations
The differential diagnosis is broad and includes trauma, septic arthritis, viral or bacterial infections, Lyme disease in endemic regions, rheumatic fever, connective tissue diseases, orthopedic disorders such as Legg–Calvé–Perthes disease, and malignancy. Severe pain out of proportion to exam findings or midshaft bone pain should raise concern for neoplasm.
Management In The Emergency Setting
Emergency care focuses on identifying serious alternative diagnoses and stabilizing ill-appearing children. Toxic-appearing patients require prompt supportive care, including oxygen and intravenous access. For known JIA patients presenting with disease flares, management should be coordinated with the child’s rheumatologist. Antibiotics are reserved for confirmed or strongly suspected joint infection.
Pharmacologic Therapy Principles
Treatment strategies aim to control inflammation, preserve joint function, and support normal growth. Mild forms of JIA may respond to nonsteroidal anti-inflammatory drugs alone, while more severe or systemic disease often necessitates disease-modifying antirheumatic drugs or biologic agents. Early aggressive therapy is now common to reduce long-term complications. NSAIDs remain first-line for many patients, while intra-articular corticosteroid injections can provide prolonged relief in selected joints. Systemic corticosteroids, methotrexate, sulfasalazine, and biologic agents targeting specific cytokines are used based on disease severity and subtype, with careful monitoring for immunosuppression and adverse effects.
Disposition And Long-Term Care
Hospital admission is indicated when diagnosis is uncertain, the child appears systemically ill, or septic arthritis is suspected. Most stable patients without infection may be discharged once pain is controlled and follow-up is assured. Long-term management requires regular rheumatology care, and children—particularly those with pauciarticular disease—must undergo frequent ophthalmologic examinations to detect silent uveitis before irreversible damage occurs.
Key Clinical Insights And Common Pitfalls
Always exclude acute joint infection, particularly in endemic areas for Lyme disease. Prolonged daily fevers with arthritis unresponsive to antibiotics should prompt consideration of systemic-onset JIA. Be vigilant for macrophage activation syndrome in children with systemic disease who appear septic or deteriorate rapidly. A careful review of current medications is essential to identify adverse effects or immunosuppression that may alter presentation and risk.
Overview And Definition
Juvenile idiopathic arthritis (JIA), formerly termed juvenile rheumatoid arthritis, represents a group of chronic inflammatory arthritides beginning before 17 years of age and persisting for more than six weeks without an identifiable cause. It is the most common chronic rheumatologic disease of childhood, affecting up to 1 in 1,000 children, with a female predominance in most subtypes. JIA encompasses a heterogeneous spectrum of disease, and fewer than half of affected children achieve complete remission, with many experiencing relapsing or persistent disease into adulthood.
Pathophysiology And Disease Classification
JIA is believed to result from immune dysregulation triggered by environmental factors in genetically predisposed children. The condition is classified into several subtypes based on joint involvement, symmetry, systemic features, laboratory findings, and family history. These include systemic-onset, pauciarticular, polyarticular (RF-positive and RF-negative), psoriatic, enthesitis-related, and unclassified forms. Prognosis varies by subtype, with pauciarticular disease generally carrying the most favorable outcome.
Clinical Subtypes And Presentations
Systemic-onset JIA accounts for a minority of cases and affects boys and girls equally. It is characterized by high, quotidian fevers lasting longer than two weeks, often accompanied by arthritis that may appear weeks to months after fever onset. Additional features may include a transient salmon-colored rash, lymphadenopathy, hepatosplenomegaly, or serositis. These patients often appear acutely ill and are at significant risk for macrophage activation syndrome, a life-threatening hyperinflammatory condition with high mortality.
Pauciarticular JIA is the most common subtype and typically affects young girls between two and four years of age. It involves four or fewer joints within the first six months, most often the knees, and presents insidiously in otherwise well-appearing children. Uveitis occurs in a substantial proportion and may be asymptomatic, necessitating routine ophthalmologic screening. Some children progress to extended disease with a worse prognosis.
Polyarticular JIA involves five or more joints within six months and may resemble adult rheumatoid arthritis, particularly in older girls with positive rheumatoid factor. Joint involvement is often symmetric, affecting both small and large joints, and may include the cervical spine and temporomandibular joint. Systemic symptoms are generally mild, limited to fatigue or anemia.
Psoriatic JIA presents with asymmetric arthritis of large joints, frequently involving the lower extremities or spine, and may be associated with psoriasis, dactylitis, nail pitting, or a family history of psoriasis. Enthesitis-related arthritis primarily affects older boys and involves lower extremity joints and the sacroiliac region, often accompanied by limited spinal motion and uveitis.
History And Physical Examination
The hallmark presentation of JIA is gradual-onset joint stiffness and swelling that is worse in the morning or after periods of inactivity and improves with movement. Children with systemic-onset disease are more likely to present to the emergency department due to acute illness, whereas other subtypes evolve slowly. Rapid onset of severe pain, warmth, and erythema in a joint is atypical for JIA and should prompt evaluation for infection or other inflammatory causes. Physical examination should focus on identifying systemic illness, documenting joint involvement, assessing range of motion, and noting signs of inflammation or functional impairment.
Initial Evaluation And Diagnostic Strategy
The primary objectives in the acute setting are to exclude septic arthritis, malignancy, and other identifiable causes of joint inflammation, as well as complications related to long-term immunosuppressive therapy. Basic laboratory studies include complete blood count and inflammatory markers, with blood cultures added if the child appears ill. Additional testing such as ANA, RF, HLA-B27, and liver enzymes may aid in subtype classification. Imaging with plain radiographs may show early soft tissue swelling and effusion, with later findings including osteoporosis and joint destruction. Ultrasound is helpful for detecting small effusions and guiding arthrocentesis when infection is suspected.
Differential Diagnostic Considerations
The differential diagnosis is broad and includes trauma, septic arthritis, viral or bacterial infections, Lyme disease in endemic regions, rheumatic fever, connective tissue diseases, orthopedic disorders such as Legg–Calvé–Perthes disease, and malignancy. Severe pain out of proportion to exam findings or midshaft bone pain should raise concern for neoplasm.
Management In The Emergency Setting
Emergency care focuses on identifying serious alternative diagnoses and stabilizing ill-appearing children. Toxic-appearing patients require prompt supportive care, including oxygen and intravenous access. For known JIA patients presenting with disease flares, management should be coordinated with the child’s rheumatologist. Antibiotics are reserved for confirmed or strongly suspected joint infection.
Pharmacologic Therapy Principles
Treatment strategies aim to control inflammation, preserve joint function, and support normal growth. Mild forms of JIA may respond to nonsteroidal anti-inflammatory drugs alone, while more severe or systemic disease often necessitates disease-modifying antirheumatic drugs or biologic agents. Early aggressive therapy is now common to reduce long-term complications. NSAIDs remain first-line for many patients, while intra-articular corticosteroid injections can provide prolonged relief in selected joints. Systemic corticosteroids, methotrexate, sulfasalazine, and biologic agents targeting specific cytokines are used based on disease severity and subtype, with careful monitoring for immunosuppression and adverse effects.
Disposition And Long-Term Care
Hospital admission is indicated when diagnosis is uncertain, the child appears systemically ill, or septic arthritis is suspected. Most stable patients without infection may be discharged once pain is controlled and follow-up is assured. Long-term management requires regular rheumatology care, and children—particularly those with pauciarticular disease—must undergo frequent ophthalmologic examinations to detect silent uveitis before irreversible damage occurs.
Key Clinical Insights And Common Pitfalls
Always exclude acute joint infection, particularly in endemic areas for Lyme disease. Prolonged daily fevers with arthritis unresponsive to antibiotics should prompt consideration of systemic-onset JIA. Be vigilant for macrophage activation syndrome in children with systemic disease who appear septic or deteriorate rapidly. A careful review of current medications is essential to identify adverse effects or immunosuppression that may alter presentation and risk.
- Published on
Emergency and Acute Medicine – Degenerative Arthritis (Osteoarthritis)
Overview And Disease Background
Degenerative arthritis, commonly known as osteoarthritis, is the most prevalent progressive joint disorder and a leading cause of chronic musculoskeletal pain in older adults. It primarily affects weight-bearing and frequently used joints and represents a gradual failure of joint cartilage with secondary changes in surrounding bone and soft tissue. Although most cases occur in the elderly, younger patients may be affected following significant joint trauma.
Pathogenesis And Risk Factors
Osteoarthritis develops from cumulative mechanical stress on synovial joints over time, leading to progressive breakdown of articular cartilage. This degeneration triggers reactive bone formation at joint margins and subchondral sclerosis, resulting in reduced joint cushioning and altered biomechanics. Contributing risk factors include advancing age, obesity, prior joint injury, genetic predisposition, sex-related differences, and environmental or occupational joint loading.
Clinical Features And Symptom Pattern
Patients typically report chronic, gradually worsening joint pain that is exacerbated by activity or weight bearing and relieved with rest. Joint involvement is often asymmetric and commonly affects the knees, hips, hands, feet, and spine. Morning stiffness is brief, usually lasting less than 30 minutes, distinguishing osteoarthritis from inflammatory arthritides. As disease progresses, joint deformity and restricted range of motion become evident. Bony enlargements such as Heberden nodes at the distal interphalangeal joints and Bouchard nodes at the proximal interphalangeal joints are characteristic findings. Systemic symptoms are notably absent, and crepitus with movement is common.
Evaluation And Initial Assessment
Assessment begins with a detailed joint examination focusing on pain localization, range of motion, stability, and functional limitation. Plain radiographs are the primary imaging modality and typically demonstrate joint space narrowing, marginal osteophyte formation, subchondral sclerosis, and irregular joint contours. In the presence of joint effusion, synovial fluid analysis may be both diagnostic and therapeutic. Arthrocentesis is mandatory when warmth, erythema, or significant swelling raises concern for septic arthritis or crystalline disease. In such cases, inflammatory markers and blood counts may assist in excluding infection.
Diagnostic Findings
Synovial fluid analysis in osteoarthritis usually reveals clear fluid with mildly elevated leukocyte counts below inflammatory thresholds, a low proportion of polymorphonuclear cells, and glucose levels comparable to serum. Radiographic findings remain the cornerstone of diagnosis and correlate with structural disease, though symptom severity may not always align with imaging changes.
Differential Diagnostic Considerations
Conditions that may mimic or coexist with degenerative arthritis include gout or pseudogout, septic arthritis, rheumatoid arthritis, hemarthrosis, Charcot arthropathy, and periarticular soft tissue disorders such as bursitis or cellulitis. Careful clinical correlation is essential to avoid missed diagnoses.
Management Principles In The Emergency Setting
Treatment is individualized and directed toward symptom relief rather than radiographic severity. Acute management focuses on pain control and preservation of joint function. Temporary immobilization may be appropriate until fracture is excluded, but prolonged immobilization should be avoided. Patients should be encouraged to maintain gentle joint movement and begin strengthening exercises once pain is controlled.
Procedural And Pharmacologic Therapy
Ultrasound-guided arthrocentesis and intra-articular corticosteroid injection can provide effective symptom relief in selected patients, with or without joint effusion. Strict aseptic technique is essential, and corticosteroids must not be administered if septic arthritis cannot be confidently excluded. Medication therapy typically begins with acetaminophen due to its favorable safety profile. Nonsteroidal anti-inflammatory drugs may be added if pain persists, with careful attention to gastrointestinal and cardiovascular risk factors. Adjunctive options such as glucosamine and chondroitin may offer modest benefit in some patients. Lifestyle interventions, particularly weight reduction and muscle strengthening, play a central role in long-term disease control.
Disposition And Follow-Up Planning
Hospital admission is rarely required unless fracture, infection, or severe functional limitation is present. Most patients can be safely discharged once pain is controlled and ambulation is adequate. Follow-up with primary care, sports medicine, or orthopedics is recommended for ongoing management, rehabilitation planning, and consideration of advanced therapies if symptoms progress.
Overview And Disease Background
Degenerative arthritis, commonly known as osteoarthritis, is the most prevalent progressive joint disorder and a leading cause of chronic musculoskeletal pain in older adults. It primarily affects weight-bearing and frequently used joints and represents a gradual failure of joint cartilage with secondary changes in surrounding bone and soft tissue. Although most cases occur in the elderly, younger patients may be affected following significant joint trauma.
Pathogenesis And Risk Factors
Osteoarthritis develops from cumulative mechanical stress on synovial joints over time, leading to progressive breakdown of articular cartilage. This degeneration triggers reactive bone formation at joint margins and subchondral sclerosis, resulting in reduced joint cushioning and altered biomechanics. Contributing risk factors include advancing age, obesity, prior joint injury, genetic predisposition, sex-related differences, and environmental or occupational joint loading.
Clinical Features And Symptom Pattern
Patients typically report chronic, gradually worsening joint pain that is exacerbated by activity or weight bearing and relieved with rest. Joint involvement is often asymmetric and commonly affects the knees, hips, hands, feet, and spine. Morning stiffness is brief, usually lasting less than 30 minutes, distinguishing osteoarthritis from inflammatory arthritides. As disease progresses, joint deformity and restricted range of motion become evident. Bony enlargements such as Heberden nodes at the distal interphalangeal joints and Bouchard nodes at the proximal interphalangeal joints are characteristic findings. Systemic symptoms are notably absent, and crepitus with movement is common.
Evaluation And Initial Assessment
Assessment begins with a detailed joint examination focusing on pain localization, range of motion, stability, and functional limitation. Plain radiographs are the primary imaging modality and typically demonstrate joint space narrowing, marginal osteophyte formation, subchondral sclerosis, and irregular joint contours. In the presence of joint effusion, synovial fluid analysis may be both diagnostic and therapeutic. Arthrocentesis is mandatory when warmth, erythema, or significant swelling raises concern for septic arthritis or crystalline disease. In such cases, inflammatory markers and blood counts may assist in excluding infection.
Diagnostic Findings
Synovial fluid analysis in osteoarthritis usually reveals clear fluid with mildly elevated leukocyte counts below inflammatory thresholds, a low proportion of polymorphonuclear cells, and glucose levels comparable to serum. Radiographic findings remain the cornerstone of diagnosis and correlate with structural disease, though symptom severity may not always align with imaging changes.
Differential Diagnostic Considerations
Conditions that may mimic or coexist with degenerative arthritis include gout or pseudogout, septic arthritis, rheumatoid arthritis, hemarthrosis, Charcot arthropathy, and periarticular soft tissue disorders such as bursitis or cellulitis. Careful clinical correlation is essential to avoid missed diagnoses.
Management Principles In The Emergency Setting
Treatment is individualized and directed toward symptom relief rather than radiographic severity. Acute management focuses on pain control and preservation of joint function. Temporary immobilization may be appropriate until fracture is excluded, but prolonged immobilization should be avoided. Patients should be encouraged to maintain gentle joint movement and begin strengthening exercises once pain is controlled.
Procedural And Pharmacologic Therapy
Ultrasound-guided arthrocentesis and intra-articular corticosteroid injection can provide effective symptom relief in selected patients, with or without joint effusion. Strict aseptic technique is essential, and corticosteroids must not be administered if septic arthritis cannot be confidently excluded. Medication therapy typically begins with acetaminophen due to its favorable safety profile. Nonsteroidal anti-inflammatory drugs may be added if pain persists, with careful attention to gastrointestinal and cardiovascular risk factors. Adjunctive options such as glucosamine and chondroitin may offer modest benefit in some patients. Lifestyle interventions, particularly weight reduction and muscle strengthening, play a central role in long-term disease control.
Disposition And Follow-Up Planning
Hospital admission is rarely required unless fracture, infection, or severe functional limitation is present. Most patients can be safely discharged once pain is controlled and ambulation is adequate. Follow-up with primary care, sports medicine, or orthopedics is recommended for ongoing management, rehabilitation planning, and consideration of advanced therapies if symptoms progress.
- Published on
Emergency and Acute Medicine – Acute Arterial Occlusion
Overview And Core Concepts
Acute arterial occlusion represents a sudden and critical interruption of blood flow to an extremity, placing limb viability at immediate risk. This condition most commonly results from embolic obstruction, in situ thrombosis, arterial dissection, or traumatic vascular injury. Without prompt restoration of perfusion, irreversible ischemic damage typically develops within six hours, leading to functional impairment or limb loss. In patients with chronic arterial disease, preexisting collateral circulation may delay tissue necrosis beyond this window.
Pathophysiology And Mechanisms
Embolic occlusion usually arises from thrombus or atherosclerotic debris originating in the heart or proximal arteries, frequently lodging at sites of abrupt arterial narrowing. Thrombosis often occurs on a background of atherosclerosis, vascular grafts, aneurysms, or hypercoagulable states. Traumatic causes include penetrating or blunt injury resulting in intimal disruption, dissection, transection, or compressive vascular damage. Iatrogenic injury may follow catheterization or endovascular procedures. The resulting ischemia leads to progressive nerve and muscle dysfunction as metabolic waste accumulates and oxygen delivery ceases.
Clinical Presentation
Patients classically present with the abrupt onset of severe limb pain accompanied by coldness and pallor. The hallmark features are described by the “six Ps”: pain, pallor, paresthesias, paralysis, pulselessness, and poikilothermia. Sensory disturbances typically precede motor weakness, beginning distally and progressing proximally. In embolic events, symptoms are sudden and dramatic, whereas thrombotic occlusion may evolve more gradually. Advanced ischemia is suggested by absent capillary refill, skin mottling, cyanosis, and profound neurologic deficits, all of which indicate a poor prognosis. A subset of patients may develop painful blue or violaceous discoloration of the toes, known as blue toe syndrome.
History And Physical Examination
Accurate determination of symptom onset is essential, as ischemic duration strongly predicts outcome. A history of claudication, atrial fibrillation, recent myocardial infarction, valvular disease, vascular interventions, or trauma should be sought. Examination focuses on documenting sensory loss, muscle strength, skin temperature and color, and pulse deficits. Signs of chronic arterial insufficiency, such as hair loss and atrophic skin, may indicate underlying peripheral vascular disease. Measurement of the ankle–brachial index is helpful, with values below 0.5 strongly suggesting acute occlusion.
Diagnostic Strategy
Acute arterial occlusion is primarily a clinical diagnosis, and management decisions should not be delayed for extensive testing. Laboratory studies assess metabolic derangements and muscle injury, including electrolytes, renal function, complete blood count, and creatine phosphokinase. Duplex ultrasonography may assist in localizing arterial obstruction, while CT angiography or MR angiography can provide detailed vascular mapping when time and patient stability permit. Angiography remains useful for definitive classification and planning intervention but is often performed in conjunction with treatment.
Severity Classification
Limbs are categorized as viable, threatened, or nonviable based on neurologic findings, capillary refill, and Doppler signals. Viable limbs have pain without sensory or motor loss and require urgent but not immediate intervention. Threatened limbs show sensory deficits with or without weakness and mandate prompt revascularization. Nonviable limbs exhibit paralysis, profound sensory loss, absent capillary flow, and skin marbling, indicating irreversible ischemia and the need for amputation.
Management In The Emergency Setting
Initial care prioritizes rapid recognition, vascular surgery consultation, and anticoagulation. The affected limb should be kept dependent and protected from temperature extremes; elevation or application of heat or ice is contraindicated. Systemic anticoagulation with intravenous unfractionated heparin should be initiated promptly unless contraindicated. Analgesia and supplemental oxygen are provided as needed. Definitive treatment depends on limb viability and includes surgical embolectomy, thrombolysis, endovascular repair, or bypass. Nonviable limbs require urgent amputation to prevent systemic complications.
Disposition And Follow-Up
All patients with suspected acute arterial occlusion require hospital admission following emergent vascular consultation. Patients with chronic occlusive disease who have stable symptoms and preserved perfusion may be discharged with close outpatient vascular follow-up, provided no acute precipitating factors are identified and clear return precautions are given.
Clinical Insights And Common Pitfalls
Acute arterial occlusion is a limb-threatening emergency in which time to reperfusion is critical. Absence of pain does not exclude severe ischemia, as sensory loss may reflect advanced nerve injury. Normal skin color early in the course can be misleading, and pulselessness is often a late finding. Limb elevation or thermal manipulation can worsen ischemia and should be avoided. Early anticoagulation and rapid surgical involvement are essential to maximize limb salvage and patient outcomes.
Overview And Core Concepts
Acute arterial occlusion represents a sudden and critical interruption of blood flow to an extremity, placing limb viability at immediate risk. This condition most commonly results from embolic obstruction, in situ thrombosis, arterial dissection, or traumatic vascular injury. Without prompt restoration of perfusion, irreversible ischemic damage typically develops within six hours, leading to functional impairment or limb loss. In patients with chronic arterial disease, preexisting collateral circulation may delay tissue necrosis beyond this window.
Pathophysiology And Mechanisms
Embolic occlusion usually arises from thrombus or atherosclerotic debris originating in the heart or proximal arteries, frequently lodging at sites of abrupt arterial narrowing. Thrombosis often occurs on a background of atherosclerosis, vascular grafts, aneurysms, or hypercoagulable states. Traumatic causes include penetrating or blunt injury resulting in intimal disruption, dissection, transection, or compressive vascular damage. Iatrogenic injury may follow catheterization or endovascular procedures. The resulting ischemia leads to progressive nerve and muscle dysfunction as metabolic waste accumulates and oxygen delivery ceases.
Clinical Presentation
Patients classically present with the abrupt onset of severe limb pain accompanied by coldness and pallor. The hallmark features are described by the “six Ps”: pain, pallor, paresthesias, paralysis, pulselessness, and poikilothermia. Sensory disturbances typically precede motor weakness, beginning distally and progressing proximally. In embolic events, symptoms are sudden and dramatic, whereas thrombotic occlusion may evolve more gradually. Advanced ischemia is suggested by absent capillary refill, skin mottling, cyanosis, and profound neurologic deficits, all of which indicate a poor prognosis. A subset of patients may develop painful blue or violaceous discoloration of the toes, known as blue toe syndrome.
History And Physical Examination
Accurate determination of symptom onset is essential, as ischemic duration strongly predicts outcome. A history of claudication, atrial fibrillation, recent myocardial infarction, valvular disease, vascular interventions, or trauma should be sought. Examination focuses on documenting sensory loss, muscle strength, skin temperature and color, and pulse deficits. Signs of chronic arterial insufficiency, such as hair loss and atrophic skin, may indicate underlying peripheral vascular disease. Measurement of the ankle–brachial index is helpful, with values below 0.5 strongly suggesting acute occlusion.
Diagnostic Strategy
Acute arterial occlusion is primarily a clinical diagnosis, and management decisions should not be delayed for extensive testing. Laboratory studies assess metabolic derangements and muscle injury, including electrolytes, renal function, complete blood count, and creatine phosphokinase. Duplex ultrasonography may assist in localizing arterial obstruction, while CT angiography or MR angiography can provide detailed vascular mapping when time and patient stability permit. Angiography remains useful for definitive classification and planning intervention but is often performed in conjunction with treatment.
Severity Classification
Limbs are categorized as viable, threatened, or nonviable based on neurologic findings, capillary refill, and Doppler signals. Viable limbs have pain without sensory or motor loss and require urgent but not immediate intervention. Threatened limbs show sensory deficits with or without weakness and mandate prompt revascularization. Nonviable limbs exhibit paralysis, profound sensory loss, absent capillary flow, and skin marbling, indicating irreversible ischemia and the need for amputation.
Management In The Emergency Setting
Initial care prioritizes rapid recognition, vascular surgery consultation, and anticoagulation. The affected limb should be kept dependent and protected from temperature extremes; elevation or application of heat or ice is contraindicated. Systemic anticoagulation with intravenous unfractionated heparin should be initiated promptly unless contraindicated. Analgesia and supplemental oxygen are provided as needed. Definitive treatment depends on limb viability and includes surgical embolectomy, thrombolysis, endovascular repair, or bypass. Nonviable limbs require urgent amputation to prevent systemic complications.
Disposition And Follow-Up
All patients with suspected acute arterial occlusion require hospital admission following emergent vascular consultation. Patients with chronic occlusive disease who have stable symptoms and preserved perfusion may be discharged with close outpatient vascular follow-up, provided no acute precipitating factors are identified and clear return precautions are given.
Clinical Insights And Common Pitfalls
Acute arterial occlusion is a limb-threatening emergency in which time to reperfusion is critical. Absence of pain does not exclude severe ischemia, as sensory loss may reflect advanced nerve injury. Normal skin color early in the course can be misleading, and pulselessness is often a late finding. Limb elevation or thermal manipulation can worsen ischemia and should be avoided. Early anticoagulation and rapid surgical involvement are essential to maximize limb salvage and patient outcomes.
- Published on
Emergency and Acute Medicine – Arterial Gas Embolism
Overview And Pathophysiology
Arterial gas embolism occurs when air enters the pulmonary venous circulation, most commonly after alveolar rupture, and is then distributed through the systemic arterial system. Clinical effects depend on where gas bubbles lodge, particularly within cerebral, coronary, or other end-organ circulations. This condition is also referred to as dysbaric air embolism or cerebral air embolism. It typically results from lung overpressurization, where trapped intrapulmonary air expands during ascent, tears alveoli, and gains access to the vasculature. The underlying mechanism follows Boyle’s law, in which gas volume increases as ambient pressure decreases during ascent.
Causes And Risk Factors
The most common cause is breath-holding during ascent from a compressed-air dive, leading to rapid lung overexpansion and widespread arterial bubble dissemination. Arterial gas embolism may also occur through pulmonary arteriovenous shunts or paradoxical embolization via a patent foramen ovale. Nondiving causes include iatrogenic introduction of air during central venous catheter placement, cardiothoracic surgery, or hemodialysis, as well as penetrating cardiac trauma requiring emergent repair.
Clinical Presentation
Symptoms usually begin abruptly, with nearly all dive-related cases presenting within the first 5–10 minutes after surfacing, often within the first 2 minutes. Neurologic involvement predominates and may resemble an acute stroke, ranging from confusion and focal deficits to seizures, coma, or cardiopulmonary arrest. Transient improvement may occur as bubbles redistribute, but relapse is common and should not reassure clinicians. Pulmonary findings include dyspnea, pleuritic chest pain, hemoptysis, and subcutaneous emphysema. Cardiac involvement may manifest as myocardial ischemia, reduced cardiac output from intracardiac air, or a characteristic precordial crunch known as Hamman sign. Renal infarction and other end-organ ischemia may also occur.
History And Examination
A focused history should establish the timing of symptom onset relative to dive ascent or procedural intervention, as rapid onset strongly supports the diagnosis. Inquiry into breath-holding, panic, equipment malfunction, or unusual ascent conditions is essential. Physical examination must emphasize a detailed neurologic assessment, documenting motor, sensory, cerebellar, and cranial nerve findings, as presentations are highly variable.
Diagnostic Approach
Arterial gas embolism is primarily a clinical diagnosis based on exposure history and abrupt symptom onset. Laboratory studies may show elevated creatine kinase as a marker of cerebral injury, along with routine assessment of electrolytes, renal function, and arterial blood gases when respiratory compromise is present. Imaging may reveal pneumothorax or mediastinal emphysema on chest radiography, while chest CT can identify lung injury or hemorrhage. Neuroimaging may demonstrate cerebral air but should never delay definitive therapy. Echocardiography may identify a patent foramen ovale. When suspicion is high, treatment should proceed without waiting for confirmatory imaging.
Differential Considerations
Key alternatives include ischemic stroke unrelated to diving and neurologic manifestations of decompression sickness. Timing of onset, rapid progression, and association with ascent strongly favor arterial gas embolism.
Initial Stabilization And Emergency Care
Immediate management focuses on airway, breathing, and circulation. High-flow 100% oxygen should be administered via a tight-fitting mask to reduce bubble size and improve tissue oxygenation. Early intubation is indicated for airway protection or respiratory failure. Intravenous access and volume resuscitation should be established promptly. Patients should be handled carefully, as neurologic status may fluctuate.
Definitive Management
Hyperbaric oxygen therapy is the cornerstone of treatment for all cases of arterial gas embolism and should be initiated as soon as possible. Early coordination with the nearest hyperbaric facility is critical, with transport in aircraft capable of maintaining low cabin altitude when required. A prophylactic chest tube may be placed in patients with pneumothorax to prevent deterioration during recompression. Endotracheal tube and Foley catheter balloons should be filled with saline or water rather than air to avoid expansion-related injury. Consultation with specialized dive medicine services is strongly recommended.
Disposition And Follow-Up
All patients require hospital admission following initial hyperbaric therapy for observation and repeat neurologic evaluation. Discharge directly from the emergency department is not appropriate for any patient with suspected or confirmed arterial gas embolism. Ongoing hyperbaric follow-up is required based on clinical response.
Clinical Cautions And Diagnostic Pitfalls
Arterial gas embolism should be suspected when neurologic symptoms develop during ascent or within minutes of surfacing, or after procedures with risk of intravascular air. Apparent rapid neurologic recovery is unreliable and does not exclude severe injury, as symptom recurrence is common. Definitive treatment should never be delayed for imaging when clinical suspicion is high. During recompression, all air-filled device balloons must be replaced with fluid to prevent expansion-related complications.
Overview And Pathophysiology
Arterial gas embolism occurs when air enters the pulmonary venous circulation, most commonly after alveolar rupture, and is then distributed through the systemic arterial system. Clinical effects depend on where gas bubbles lodge, particularly within cerebral, coronary, or other end-organ circulations. This condition is also referred to as dysbaric air embolism or cerebral air embolism. It typically results from lung overpressurization, where trapped intrapulmonary air expands during ascent, tears alveoli, and gains access to the vasculature. The underlying mechanism follows Boyle’s law, in which gas volume increases as ambient pressure decreases during ascent.
Causes And Risk Factors
The most common cause is breath-holding during ascent from a compressed-air dive, leading to rapid lung overexpansion and widespread arterial bubble dissemination. Arterial gas embolism may also occur through pulmonary arteriovenous shunts or paradoxical embolization via a patent foramen ovale. Nondiving causes include iatrogenic introduction of air during central venous catheter placement, cardiothoracic surgery, or hemodialysis, as well as penetrating cardiac trauma requiring emergent repair.
Clinical Presentation
Symptoms usually begin abruptly, with nearly all dive-related cases presenting within the first 5–10 minutes after surfacing, often within the first 2 minutes. Neurologic involvement predominates and may resemble an acute stroke, ranging from confusion and focal deficits to seizures, coma, or cardiopulmonary arrest. Transient improvement may occur as bubbles redistribute, but relapse is common and should not reassure clinicians. Pulmonary findings include dyspnea, pleuritic chest pain, hemoptysis, and subcutaneous emphysema. Cardiac involvement may manifest as myocardial ischemia, reduced cardiac output from intracardiac air, or a characteristic precordial crunch known as Hamman sign. Renal infarction and other end-organ ischemia may also occur.
History And Examination
A focused history should establish the timing of symptom onset relative to dive ascent or procedural intervention, as rapid onset strongly supports the diagnosis. Inquiry into breath-holding, panic, equipment malfunction, or unusual ascent conditions is essential. Physical examination must emphasize a detailed neurologic assessment, documenting motor, sensory, cerebellar, and cranial nerve findings, as presentations are highly variable.
Diagnostic Approach
Arterial gas embolism is primarily a clinical diagnosis based on exposure history and abrupt symptom onset. Laboratory studies may show elevated creatine kinase as a marker of cerebral injury, along with routine assessment of electrolytes, renal function, and arterial blood gases when respiratory compromise is present. Imaging may reveal pneumothorax or mediastinal emphysema on chest radiography, while chest CT can identify lung injury or hemorrhage. Neuroimaging may demonstrate cerebral air but should never delay definitive therapy. Echocardiography may identify a patent foramen ovale. When suspicion is high, treatment should proceed without waiting for confirmatory imaging.
Differential Considerations
Key alternatives include ischemic stroke unrelated to diving and neurologic manifestations of decompression sickness. Timing of onset, rapid progression, and association with ascent strongly favor arterial gas embolism.
Initial Stabilization And Emergency Care
Immediate management focuses on airway, breathing, and circulation. High-flow 100% oxygen should be administered via a tight-fitting mask to reduce bubble size and improve tissue oxygenation. Early intubation is indicated for airway protection or respiratory failure. Intravenous access and volume resuscitation should be established promptly. Patients should be handled carefully, as neurologic status may fluctuate.
Definitive Management
Hyperbaric oxygen therapy is the cornerstone of treatment for all cases of arterial gas embolism and should be initiated as soon as possible. Early coordination with the nearest hyperbaric facility is critical, with transport in aircraft capable of maintaining low cabin altitude when required. A prophylactic chest tube may be placed in patients with pneumothorax to prevent deterioration during recompression. Endotracheal tube and Foley catheter balloons should be filled with saline or water rather than air to avoid expansion-related injury. Consultation with specialized dive medicine services is strongly recommended.
Disposition And Follow-Up
All patients require hospital admission following initial hyperbaric therapy for observation and repeat neurologic evaluation. Discharge directly from the emergency department is not appropriate for any patient with suspected or confirmed arterial gas embolism. Ongoing hyperbaric follow-up is required based on clinical response.
Clinical Cautions And Diagnostic Pitfalls
Arterial gas embolism should be suspected when neurologic symptoms develop during ascent or within minutes of surfacing, or after procedures with risk of intravascular air. Apparent rapid neurologic recovery is unreliable and does not exclude severe injury, as symptom recurrence is common. Definitive treatment should never be delayed for imaging when clinical suspicion is high. During recompression, all air-filled device balloons must be replaced with fluid to prevent expansion-related complications.
- Published on
Emergency and Acute Medicine – Bladder Injury
Overview and Definitions
Bladder injury most commonly results from blunt trauma. Approximately 10% of patients with pelvic fractures sustain significant bladder injury, and 80–90% of bladder ruptures are associated with pelvic fractures. Overall mortality ranges from 17–22%, increasing to nearly 60% in combined intraperitoneal and extraperitoneal ruptures.
Etiology and Classification
Trauma accounts for about 82% of bladder injuries. Blunt mechanisms include motor vehicle accidents (87%), falls (7%), and assault (6%). Penetrating injuries are most often due to gunshot wounds (85%) and stabbings (15%). Iatrogenic causes account for 14% and include TURP, urologic, gynecologic, obstetric, abdominal, and orthopedic hip procedures, biopsies, indwelling Foley catheters, and IUD placement. Intoxication accounts for 2.9%, and spontaneous rupture occurs in less than 1%.
Extraperitoneal rupture (62%) is usually associated with pelvic fractures and results from blunt force or bone fragments. Intraperitoneal rupture (25%) occurs from direct compression of a distended bladder, typically involving the bladder dome. Combined intraperitoneal and extraperitoneal rupture (12%) carries the highest mortality due to associated injuries. Bladder contusion involves injury to the endothelial lining or muscularis with an intact bladder wall and may cause gross hematuria with normal imaging; it usually resolves without intervention.
In children, the bladder is intra-abdominal until late adolescence, making intraperitoneal rupture more common and overall bladder injury more frequent due to a less rigid pelvis.
Clinical Presentation
The classic triad includes gross hematuria, suprapubic pain, and difficulty voiding. History should focus on traumatic mechanism or recent procedures. On examination, the urethral meatus must be inspected; if blood is present, Foley catheter placement should be deferred until a retrograde urethrogram is performed, as concomitant urethral injury occurs in 10–29% of cases.
Evaluation and Diagnostic Testing
Initial evaluation includes urinalysis, which shows gross hematuria in 95–100% of significant injuries and microscopic hematuria in about 5%. BUN may be elevated due to intraperitoneal urine resorption, and electrolyte abnormalities such as hyperkalemia or hypernatremia may be present.
Retrograde cystography or CT cystography is the diagnostic modality of choice, with sensitivity around 95% and specificity near 100%. If urethral injury is suspected, a retrograde urethrogram is performed first. Proper cystography requires adequate bladder distension with diluted contrast and postdrainage imaging, as up to 10% of ruptures are detected only after bladder emptying. Extraperitoneal ruptures show teardrop- or star-shaped extravasation, whereas intraperitoneal ruptures demonstrate contrast outlining bowel loops or filling paracolic gutters. FAST examination showing free pelvic fluid should heighten suspicion for bladder injury.
Differential Diagnosis
Consider peritoneal trauma, urethral injury, and renal or ureteral trauma.
Management
Prehospital bladder catheterization should be avoided. Initial management follows standard ABCs with early urologic consultation. Extraperitoneal nonpenetrating ruptures may be managed with Foley catheter drainage (20F or larger) for approximately 14 days, with most lacerations sealing within 3 weeks; surgical repair is recommended if the patient is undergoing pelvic or abdominal surgery for other injuries. Intraperitoneal ruptures require surgical exploration and repair. Bladder contusions require no specific intervention. Broad-spectrum antibiotics are indicated for intraperitoneal rupture.
Disposition and Follow-Up
Admission is required for patients with associated major trauma or those needing surgical intervention. Bladder contusions without rupture and without other injuries may be discharged. Most bladder ruptures require admission, and discharge should occur only after urologic clearance. Urology follow-up is required for all outpatient-managed injuries, with Foley catheter removal typically at 14 days for conservatively managed extraperitoneal ruptures.
Clinical Insights and Common Errors
Free pelvic fluid on CT or ultrasound should prompt concern for bladder injury. Unresponsive, intoxicated, or altered patients require careful evaluation. Any penetrating injury to the lower abdomen with hematuria warrants cystography.
Overview and Definitions
Bladder injury most commonly results from blunt trauma. Approximately 10% of patients with pelvic fractures sustain significant bladder injury, and 80–90% of bladder ruptures are associated with pelvic fractures. Overall mortality ranges from 17–22%, increasing to nearly 60% in combined intraperitoneal and extraperitoneal ruptures.
Etiology and Classification
Trauma accounts for about 82% of bladder injuries. Blunt mechanisms include motor vehicle accidents (87%), falls (7%), and assault (6%). Penetrating injuries are most often due to gunshot wounds (85%) and stabbings (15%). Iatrogenic causes account for 14% and include TURP, urologic, gynecologic, obstetric, abdominal, and orthopedic hip procedures, biopsies, indwelling Foley catheters, and IUD placement. Intoxication accounts for 2.9%, and spontaneous rupture occurs in less than 1%.
Extraperitoneal rupture (62%) is usually associated with pelvic fractures and results from blunt force or bone fragments. Intraperitoneal rupture (25%) occurs from direct compression of a distended bladder, typically involving the bladder dome. Combined intraperitoneal and extraperitoneal rupture (12%) carries the highest mortality due to associated injuries. Bladder contusion involves injury to the endothelial lining or muscularis with an intact bladder wall and may cause gross hematuria with normal imaging; it usually resolves without intervention.
In children, the bladder is intra-abdominal until late adolescence, making intraperitoneal rupture more common and overall bladder injury more frequent due to a less rigid pelvis.
Clinical Presentation
The classic triad includes gross hematuria, suprapubic pain, and difficulty voiding. History should focus on traumatic mechanism or recent procedures. On examination, the urethral meatus must be inspected; if blood is present, Foley catheter placement should be deferred until a retrograde urethrogram is performed, as concomitant urethral injury occurs in 10–29% of cases.
Evaluation and Diagnostic Testing
Initial evaluation includes urinalysis, which shows gross hematuria in 95–100% of significant injuries and microscopic hematuria in about 5%. BUN may be elevated due to intraperitoneal urine resorption, and electrolyte abnormalities such as hyperkalemia or hypernatremia may be present.
Retrograde cystography or CT cystography is the diagnostic modality of choice, with sensitivity around 95% and specificity near 100%. If urethral injury is suspected, a retrograde urethrogram is performed first. Proper cystography requires adequate bladder distension with diluted contrast and postdrainage imaging, as up to 10% of ruptures are detected only after bladder emptying. Extraperitoneal ruptures show teardrop- or star-shaped extravasation, whereas intraperitoneal ruptures demonstrate contrast outlining bowel loops or filling paracolic gutters. FAST examination showing free pelvic fluid should heighten suspicion for bladder injury.
Differential Diagnosis
Consider peritoneal trauma, urethral injury, and renal or ureteral trauma.
Management
Prehospital bladder catheterization should be avoided. Initial management follows standard ABCs with early urologic consultation. Extraperitoneal nonpenetrating ruptures may be managed with Foley catheter drainage (20F or larger) for approximately 14 days, with most lacerations sealing within 3 weeks; surgical repair is recommended if the patient is undergoing pelvic or abdominal surgery for other injuries. Intraperitoneal ruptures require surgical exploration and repair. Bladder contusions require no specific intervention. Broad-spectrum antibiotics are indicated for intraperitoneal rupture.
Disposition and Follow-Up
Admission is required for patients with associated major trauma or those needing surgical intervention. Bladder contusions without rupture and without other injuries may be discharged. Most bladder ruptures require admission, and discharge should occur only after urologic clearance. Urology follow-up is required for all outpatient-managed injuries, with Foley catheter removal typically at 14 days for conservatively managed extraperitoneal ruptures.
Clinical Insights and Common Errors
Free pelvic fluid on CT or ultrasound should prompt concern for bladder injury. Unresponsive, intoxicated, or altered patients require careful evaluation. Any penetrating injury to the lower abdomen with hematuria warrants cystography.
- Published on
Emergency and Acute Medicine – Septic Arthritis
Clinical Overview
Septic arthritis is an acute, destructive joint infection most commonly caused by bacterial seeding of the synovial space through hematogenous spread, though direct inoculation, invasive procedures, or contiguous spread from adjacent infection may also occur. The inflammatory response leads to rapid leukocyte migration into the joint, synovial proliferation, cartilage destruction, and purulent effusion. Permanent loss of joint function occurs in a substantial proportion of patients, and reported mortality remains significant. Early recognition and intervention are therefore critical.
In children, the hip is the most frequently involved joint, often following upper respiratory or ear infections or femoral venipuncture. Infants may present nonspecifically with irritability, fever, and poor feeding, whereas older children more commonly present with fever, limp, or refusal to bear weight. Pediatric hip infections carry a high risk of serious complications including avascular necrosis, epiphyseal separation, pathologic dislocation, and early degenerative arthritis.
Predisposing Factors And Microbiology
Risk is increased at the extremes of age, in patients with underlying joint disease such as rheumatoid or degenerative arthritis, intravenous drug use, endocarditis, immunosuppression, diabetes, malignancy, chronic steroid use, recent joint injections, trauma, prosthetic joints, or overlying skin infection. No organism is identified in a minority of cases.
Staphylococcus aureus remains the most common pathogen overall, particularly in adults, hip infections, and patients with rheumatoid arthritis or diabetes. Community-acquired MRSA is increasingly prevalent in some regions. Neisseria gonorrhoeae is the leading cause in young, sexually active individuals, often presenting with disseminated disease. Other causative organisms include streptococcal species, gram-negative rods such as Pseudomonas and Escherichia coli, Neisseria meningitidis, anaerobes, and, less commonly, mycobacteria or fungi in immunocompromised hosts.
Clinical Presentation
Septic arthritis typically presents with abrupt onset of severe joint pain, swelling, warmth, and marked tenderness, with pain on both active and passive movement. Fever is common but may be absent, particularly in older adults or those with rheumatoid arthritis. Joint effusion may be subtle in deep joints such as the hip, shoulder, or sacroiliac joint. Although any joint may be involved, the knee is most common, followed by the hip, shoulder, and ankle. Intravenous drug users frequently develop infections in atypical sites including the sacroiliac, sternoclavicular, and costochondral joints.
Polyarticular involvement occurs in a minority of cases and is more frequent in patients with rheumatoid arthritis, often leading to delayed diagnosis due to less dramatic presentations. Gonococcal septic arthritis may be monoarticular or migratory and is frequently associated with tenosynovitis, dermatitis, and subtle genitourinary symptoms.
Diagnostic Strategy
Prompt arthrocentesis is essential in all suspected cases and should not be delayed. Synovial fluid should be analyzed for cell count, differential, Gram stain, culture, glucose, and protein. Typical findings include turbid or purulent fluid with very high leukocyte counts and neutrophil predominance. Reduced synovial glucose and elevated protein further support infection. The presence of crystals does not exclude septic arthritis. Blood cultures are frequently positive and should be obtained, along with cultures from suspected primary infection sites when appropriate.
Serum inflammatory markers such as CRP and ESR are usually elevated and may assist in monitoring response to therapy. Procalcitonin may be useful as a supportive diagnostic marker. Imaging with plain radiographs helps assess baseline joint status and detect effusions, osteomyelitis, or foreign bodies. Ultrasound is valuable for detecting effusions and guiding aspiration, particularly in the hip. CT or MRI may be necessary for deep or difficult-to-access joints.
Management Principles
Patients may present septic and require immediate resuscitation. Joint aspiration should be performed promptly, but in toxic patients antibiotics should not be delayed while awaiting results. Empiric intravenous antibiotics should be initiated based on patient age, risk factors, and local resistance patterns, with coverage for staphylococci, streptococci, and gram-negative organisms as indicated. MRSA coverage should be included when risk factors are present. Suspected gonococcal infection should be treated with appropriate cephalosporins. Intra-articular antibiotics are contraindicated.
Early orthopedic consultation is essential to determine the need for surgical drainage, which may involve repeated aspirations, arthroscopy, or open arthrotomy. Pediatric hip infections typically require open surgical drainage. Adequate pain control and joint positioning to minimize further damage are important supportive measures.
Disposition And Follow-Up
All patients with suspected septic arthritis should be admitted until the diagnosis is confidently excluded. Most require prolonged intravenous antibiotic therapy and possible surgical intervention. Discharge is appropriate only when infection has been reliably ruled out. Close follow-up is required to monitor clinical response and prevent long-term complications.
Key Clinical Lessons And Common Errors
Inflammatory markers such as CRP and ESR are useful for tracking treatment response but should not replace synovial fluid analysis for diagnosis. Distinguishing septic arthritis from crystal arthropathy or transient synovitis can be challenging; when in doubt, joint aspiration is mandatory. A low threshold for arthrocentesis is essential to avoid delayed diagnosis and irreversible joint damage.
Clinical Overview
Septic arthritis is an acute, destructive joint infection most commonly caused by bacterial seeding of the synovial space through hematogenous spread, though direct inoculation, invasive procedures, or contiguous spread from adjacent infection may also occur. The inflammatory response leads to rapid leukocyte migration into the joint, synovial proliferation, cartilage destruction, and purulent effusion. Permanent loss of joint function occurs in a substantial proportion of patients, and reported mortality remains significant. Early recognition and intervention are therefore critical.
In children, the hip is the most frequently involved joint, often following upper respiratory or ear infections or femoral venipuncture. Infants may present nonspecifically with irritability, fever, and poor feeding, whereas older children more commonly present with fever, limp, or refusal to bear weight. Pediatric hip infections carry a high risk of serious complications including avascular necrosis, epiphyseal separation, pathologic dislocation, and early degenerative arthritis.
Predisposing Factors And Microbiology
Risk is increased at the extremes of age, in patients with underlying joint disease such as rheumatoid or degenerative arthritis, intravenous drug use, endocarditis, immunosuppression, diabetes, malignancy, chronic steroid use, recent joint injections, trauma, prosthetic joints, or overlying skin infection. No organism is identified in a minority of cases.
Staphylococcus aureus remains the most common pathogen overall, particularly in adults, hip infections, and patients with rheumatoid arthritis or diabetes. Community-acquired MRSA is increasingly prevalent in some regions. Neisseria gonorrhoeae is the leading cause in young, sexually active individuals, often presenting with disseminated disease. Other causative organisms include streptococcal species, gram-negative rods such as Pseudomonas and Escherichia coli, Neisseria meningitidis, anaerobes, and, less commonly, mycobacteria or fungi in immunocompromised hosts.
Clinical Presentation
Septic arthritis typically presents with abrupt onset of severe joint pain, swelling, warmth, and marked tenderness, with pain on both active and passive movement. Fever is common but may be absent, particularly in older adults or those with rheumatoid arthritis. Joint effusion may be subtle in deep joints such as the hip, shoulder, or sacroiliac joint. Although any joint may be involved, the knee is most common, followed by the hip, shoulder, and ankle. Intravenous drug users frequently develop infections in atypical sites including the sacroiliac, sternoclavicular, and costochondral joints.
Polyarticular involvement occurs in a minority of cases and is more frequent in patients with rheumatoid arthritis, often leading to delayed diagnosis due to less dramatic presentations. Gonococcal septic arthritis may be monoarticular or migratory and is frequently associated with tenosynovitis, dermatitis, and subtle genitourinary symptoms.
Diagnostic Strategy
Prompt arthrocentesis is essential in all suspected cases and should not be delayed. Synovial fluid should be analyzed for cell count, differential, Gram stain, culture, glucose, and protein. Typical findings include turbid or purulent fluid with very high leukocyte counts and neutrophil predominance. Reduced synovial glucose and elevated protein further support infection. The presence of crystals does not exclude septic arthritis. Blood cultures are frequently positive and should be obtained, along with cultures from suspected primary infection sites when appropriate.
Serum inflammatory markers such as CRP and ESR are usually elevated and may assist in monitoring response to therapy. Procalcitonin may be useful as a supportive diagnostic marker. Imaging with plain radiographs helps assess baseline joint status and detect effusions, osteomyelitis, or foreign bodies. Ultrasound is valuable for detecting effusions and guiding aspiration, particularly in the hip. CT or MRI may be necessary for deep or difficult-to-access joints.
Management Principles
Patients may present septic and require immediate resuscitation. Joint aspiration should be performed promptly, but in toxic patients antibiotics should not be delayed while awaiting results. Empiric intravenous antibiotics should be initiated based on patient age, risk factors, and local resistance patterns, with coverage for staphylococci, streptococci, and gram-negative organisms as indicated. MRSA coverage should be included when risk factors are present. Suspected gonococcal infection should be treated with appropriate cephalosporins. Intra-articular antibiotics are contraindicated.
Early orthopedic consultation is essential to determine the need for surgical drainage, which may involve repeated aspirations, arthroscopy, or open arthrotomy. Pediatric hip infections typically require open surgical drainage. Adequate pain control and joint positioning to minimize further damage are important supportive measures.
Disposition And Follow-Up
All patients with suspected septic arthritis should be admitted until the diagnosis is confidently excluded. Most require prolonged intravenous antibiotic therapy and possible surgical intervention. Discharge is appropriate only when infection has been reliably ruled out. Close follow-up is required to monitor clinical response and prevent long-term complications.
Key Clinical Lessons And Common Errors
Inflammatory markers such as CRP and ESR are useful for tracking treatment response but should not replace synovial fluid analysis for diagnosis. Distinguishing septic arthritis from crystal arthropathy or transient synovitis can be challenging; when in doubt, joint aspiration is mandatory. A low threshold for arthrocentesis is essential to avoid delayed diagnosis and irreversible joint damage.
- Published on
Emergency and Acute Medicine – Arsenic Toxicity
Overview And Definition
Arsenic toxicity may present as either an acute poisoning or a chronic exposure syndrome. Acute cases most often follow intentional ingestion, malicious poisoning, or dosing errors, with a potentially lethal dose near 2 mg/kg. Chronic toxicity develops from prolonged low-level exposure, typically through contaminated water or food, occupational contact, or traditional remedies containing arsenic. Ingestion is the most common exposure route, although inhalation of arsine gas can also result in toxicity.
Sources And Mechanism Of Injury
In emergency care, acute presentations usually involve intentional ingestion, most commonly sodium arsenate found in insecticides in the United States. Globally, environmental contamination of food and water is the predominant source. Arsenic exists in inorganic, organic, elemental, and gaseous forms, with inorganic arsenic responsible for most clinically significant poisonings. Pentavalent arsenic disrupts oxidative phosphorylation and is converted in vivo to trivalent arsenic, which binds sulfhydryl groups, interferes with cellular metabolism, impairs hemoglobin synthesis, and induces DNA damage.
Clinical Manifestations
Neurologic involvement includes altered mental status, encephalopathy, seizures, and peripheral neuropathy. Early neuropathy is often sensory, progressing to sensorimotor deficits with ongoing exposure. Cardiovascular effects include QTc prolongation, ventricular dysrhythmias, acute hypotension, or chronic hypertension. Pulmonary findings range from noncardiogenic pulmonary edema to hemorrhagic bronchitis, particularly following large ingestions or inhalational exposure. Gastrointestinal symptoms are prominent, featuring severe nausea, vomiting, abdominal pain, and profuse watery diarrhea that may resemble rice-water stools. A garlic-like odor to the breath or excreta may be present. Chronic exposure is associated with dermatologic changes, nail abnormalities, alopecia, endocrine dysfunction, anemia, vascular disease, and increased malignancy risk.
Diagnostic Evaluation
Diagnosis is based on clinical suspicion supported by laboratory testing. A spot urine arsenic level is useful for initial assessment, while definitive diagnosis requires a 24-hour urine collection with arsenic speciation to distinguish inorganic from organic forms. Serum arsenic levels are generally unhelpful due to rapid clearance. Additional evaluation includes complete blood count, renal and hepatic function tests, electrolytes, creatine phosphokinase for rhabdomyolysis, and urinalysis. Abdominal radiographs may identify radiopaque material following acute ingestion.
Differential Diagnosis
Acute arsenic poisoning can resemble severe gastroenteritis, cholera, appendicitis, toxic shock, encephalopathy, or other toxic ingestions. Chronic exposure should be considered in patients with unexplained peripheral neuropathy, Raynaud-like phenomena, hyperkeratotic skin lesions, vasculitic symptoms, or nonspecific wasting.
Initial Stabilization And Emergency Care
Management begins with airway, breathing, and circulation support, continuous cardiac monitoring, and aggressive isotonic fluid resuscitation for hypotension. Seizures are treated with benzodiazepines, and respiratory failure may require ventilatory support. Antiarrhythmic agents that prolong the QT interval should be avoided. Renal failure and severe metabolic derangements warrant early specialty consultation.
Decontamination And Definitive Treatment
Early gastrointestinal decontamination may be considered within the first hour of ingestion, though activated charcoal does not effectively bind arsenic. Whole bowel irrigation is indicated when radiopaque material is identified. Dermal exposures require immediate skin decontamination. Chelation therapy is recommended for symptomatic patients or those with significantly elevated levels and should be initiated in consultation with a medical toxicologist or poison center. Dimercaprol and oral succimer are the primary chelating agents. Hemodialysis is not routinely effective for arsenic removal but may be necessary in patients with renal failure and should be continued concurrently with chelation when indicated.
Disposition And Follow-Up
Patients with symptomatic arsenic toxicity require hospital admission, often to an intensive care unit. Asymptomatic patients with low urinary arsenic levels may be discharged with appropriate follow-up and confirmation of environmental safety. Individuals with suspected chronic exposure should undergo outpatient evaluation, repeat urine testing, and long-term surveillance.
Key Clinical Insights And Diagnostic Traps
Arsenic toxicity produces a wide range of systemic findings, frequently delaying recognition. Acute poisoning should be considered when gastrointestinal distress is accompanied by neurologic abnormalities, while chronic exposure should be suspected in patients with peripheral neuropathy and characteristic skin or nail changes. Early consultation with a poison center or medical toxicologist is critical to determine the need for chelation therapy and to avoid missed or delayed treatment.
Overview And Definition
Arsenic toxicity may present as either an acute poisoning or a chronic exposure syndrome. Acute cases most often follow intentional ingestion, malicious poisoning, or dosing errors, with a potentially lethal dose near 2 mg/kg. Chronic toxicity develops from prolonged low-level exposure, typically through contaminated water or food, occupational contact, or traditional remedies containing arsenic. Ingestion is the most common exposure route, although inhalation of arsine gas can also result in toxicity.
Sources And Mechanism Of Injury
In emergency care, acute presentations usually involve intentional ingestion, most commonly sodium arsenate found in insecticides in the United States. Globally, environmental contamination of food and water is the predominant source. Arsenic exists in inorganic, organic, elemental, and gaseous forms, with inorganic arsenic responsible for most clinically significant poisonings. Pentavalent arsenic disrupts oxidative phosphorylation and is converted in vivo to trivalent arsenic, which binds sulfhydryl groups, interferes with cellular metabolism, impairs hemoglobin synthesis, and induces DNA damage.
Clinical Manifestations
Neurologic involvement includes altered mental status, encephalopathy, seizures, and peripheral neuropathy. Early neuropathy is often sensory, progressing to sensorimotor deficits with ongoing exposure. Cardiovascular effects include QTc prolongation, ventricular dysrhythmias, acute hypotension, or chronic hypertension. Pulmonary findings range from noncardiogenic pulmonary edema to hemorrhagic bronchitis, particularly following large ingestions or inhalational exposure. Gastrointestinal symptoms are prominent, featuring severe nausea, vomiting, abdominal pain, and profuse watery diarrhea that may resemble rice-water stools. A garlic-like odor to the breath or excreta may be present. Chronic exposure is associated with dermatologic changes, nail abnormalities, alopecia, endocrine dysfunction, anemia, vascular disease, and increased malignancy risk.
Diagnostic Evaluation
Diagnosis is based on clinical suspicion supported by laboratory testing. A spot urine arsenic level is useful for initial assessment, while definitive diagnosis requires a 24-hour urine collection with arsenic speciation to distinguish inorganic from organic forms. Serum arsenic levels are generally unhelpful due to rapid clearance. Additional evaluation includes complete blood count, renal and hepatic function tests, electrolytes, creatine phosphokinase for rhabdomyolysis, and urinalysis. Abdominal radiographs may identify radiopaque material following acute ingestion.
Differential Diagnosis
Acute arsenic poisoning can resemble severe gastroenteritis, cholera, appendicitis, toxic shock, encephalopathy, or other toxic ingestions. Chronic exposure should be considered in patients with unexplained peripheral neuropathy, Raynaud-like phenomena, hyperkeratotic skin lesions, vasculitic symptoms, or nonspecific wasting.
Initial Stabilization And Emergency Care
Management begins with airway, breathing, and circulation support, continuous cardiac monitoring, and aggressive isotonic fluid resuscitation for hypotension. Seizures are treated with benzodiazepines, and respiratory failure may require ventilatory support. Antiarrhythmic agents that prolong the QT interval should be avoided. Renal failure and severe metabolic derangements warrant early specialty consultation.
Decontamination And Definitive Treatment
Early gastrointestinal decontamination may be considered within the first hour of ingestion, though activated charcoal does not effectively bind arsenic. Whole bowel irrigation is indicated when radiopaque material is identified. Dermal exposures require immediate skin decontamination. Chelation therapy is recommended for symptomatic patients or those with significantly elevated levels and should be initiated in consultation with a medical toxicologist or poison center. Dimercaprol and oral succimer are the primary chelating agents. Hemodialysis is not routinely effective for arsenic removal but may be necessary in patients with renal failure and should be continued concurrently with chelation when indicated.
Disposition And Follow-Up
Patients with symptomatic arsenic toxicity require hospital admission, often to an intensive care unit. Asymptomatic patients with low urinary arsenic levels may be discharged with appropriate follow-up and confirmation of environmental safety. Individuals with suspected chronic exposure should undergo outpatient evaluation, repeat urine testing, and long-term surveillance.
Key Clinical Insights And Diagnostic Traps
Arsenic toxicity produces a wide range of systemic findings, frequently delaying recognition. Acute poisoning should be considered when gastrointestinal distress is accompanied by neurologic abnormalities, while chronic exposure should be suspected in patients with peripheral neuropathy and characteristic skin or nail changes. Early consultation with a poison center or medical toxicologist is critical to determine the need for chelation therapy and to avoid missed or delayed treatment.
